Trulicity 4.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F19MH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,067
Award facts
- Contract value 100% obligated
- $16,066.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,066.77 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens on December 12, 2025, with an ultimate completion date of December 15, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designations and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication commonly used within military and federal healthcare systems to support patient treatment protocols across the Department of Defense medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp regularly fulfills federal medical procurement requirements through this prime contract vehicle, supplying a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other government health systems worldwide. The company's established relationship with DLA reflects its capability to meet federal procurement requirements and serve critical defense health needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F19MH?
SPE2DR26F19MH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F19MH worth?
The government has obligated $16,067 on SPE2DR26F19MH.
Is contract SPE2DR26F19MH an order under another contract?
Yes. SPE2DR26F19MH is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F19MH competed?
The extent of competition for SPE2DR26F19MH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award